Latest news
Arrowhead: Buy Rating Reiterated as Redemplo Momentum Builds and Pipeline Catalysts Support Unchanged $120 Price Target - TipRanksTipRanks · Wed, 05 Aug 2026 15:37:00 GMTArrowhead Pharmaceuticals Q3 Earnings Call Highlights - TradingViewTradingView · Tue, 04 Aug 2026 22:03:56 GMTCRISPR Therapeutics' Q2 Earnings & Revenues Surpass Estimates - TradingViewTradingView · Tue, 04 Aug 2026 14:56:00 GMTCRISPR Therapeutics Reports Second Quarter 2026 Financial Results and Pipeline Updates - Quiver QuantitativeQuiver Quantitative · Mon, 03 Aug 2026 20:23:00 GMTWhy payers should have these 3 pipeline drugs on their radar - Fierce HealthcareFierce Healthcare · Mon, 03 Aug 2026 19:38:03 GMTChronic Pruritus Market Expected to Witness Significant Growth - openPR.comopenPR.com · Thu, 30 Jul 2026 15:46:53 GMTExosomes Pipeline Expands as 100+ Companies Driving Innovation in the Therapeutics | DelveInsight - openPR.comopenPR.com · Thu, 30 Jul 2026 15:46:22 GMTSevere Hypertriglyceridemia Pipeline Expands as 8+ Companies Driving Innovation in the Therapeutics | DelveInsight - openPR.comopenPR.com · Thu, 30 Jul 2026 15:31:08 GMT